Finjan Holdings, Inc. (NASDAQ: FNJN) offers investors a diversified and unique vehicle for investing in cybersecurity-related intellectual property-backed technologies under the guidance of a proven team. Finjan’s commitment to innovation in the security space continues through its investments which have … Continue reading →

Fate Therapeutics, Inc. (NASDAQ: FATE) is a clinical‑stage biopharmaceutical company engaged in the development of programmed cellular therapeutics for the treatment of severe, life‑threatening diseases. The company is primarily focused on developing programmed hematopoietic cellular candidates as therapeutic entities for … Continue reading →

Eyegate Pharmaceuticals, Inc. (OTC: EYEG), a late-stage specialty pharmaceutical and drug delivery company, is working on developing and commercializing therapeutics and drug delivery mechanisms for treating eye diseases. The company’s technology addresses two of the most prevalent issues in ophthalmic … Continue reading →

EuroSite Power, Inc. (OTC: EUSP) is a majority-owned subsidiary of American DG Energy, and has been established to expand its successful on-site utility business into the United Kingdom and Europe. The company sells the energy produced on-site by its highly … Continue reading →

Energy Fuels, Inc. (NYSE: UUUU) is America’s premier integrated uranium miner. Uranium is the fuel for nuclear, which is the true “green energy” as it provides emission-free and carbon-free electricity. Energy Fuels is positioned as a major producer of uranium … Continue reading →

Emisphere Technologies, Inc. (EMIS) is a specialty pharmaceutical company that recently commenced commercial operations. The company launched its first prescription product, oral Eligen B12, in the U.S. in March 2015. Beyond Eligen B12, the company utilizes its proprietary Eligen(R) Technology … Continue reading →

Emisphere Technologies, Inc. (OTCBB: EMIS), a commercial stage, specialty pharmaceutical company, is currently preparing to launch its first prescription product, oral Eligen B12, in the United States. Beyond Eligen B12, the company employs its proprietary Eligen Technology to create new … Continue reading →

eMagin Corporation (NYSE: EMAN) is a leading manufacturer of active-matrix Organic LED (AM-OLED) microdisplays on silicon. These displays perform at low-power levels, extended temperature ranges and provide image performance not possible with LCD technologies. The company’s OLED microdisplays are designed … Continue reading →

Elite Pharmaceuticals, Inc. (OTCQB: ELTP) is a specialty pharmaceutical companydeveloping a pipeline of proprietary pharmacological abuse-deterrent opioid products and niche generic products. Elite specializes in oral sustained and controlled release drug products with high barriers to entry. The company has … Continue reading →

Echo Therapeutics, Inc. (NASDAQ: ECTE) is changing the blood glucose monitoring industry. The company has successfully demonstrated the ability to continuously monitor blood glucose non-invasively in healthy, Type I, Type II and hospital patients. Echo’s precise exfoliator is a revolution … Continue reading →